The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dobrynina L.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Kalashnikova L.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Shabalina A.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Kostyreva M.V.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Aleksandrova E.V.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Gafarova M.E.

Neurology Research Center, Moscow, Russia

Shamtieva K.V.

Neurology Research Center, Moscow, Russia

Indicators of homeostasis, inflammation and homocysteine in ischemic stroke in the young age

Authors:

Dobrynina L.A., Kalashnikova L.A., Shabalina A.A., Kostyreva M.V., Aleksandrova E.V., Gafarova M.E., Shamtieva K.V.

More about the authors

Read: 2683 times


To cite this article:

Dobrynina LA, Kalashnikova LA, Shabalina AA, Kostyreva MV, Aleksandrova EV, Gafarova ME, Shamtieva KV. Indicators of homeostasis, inflammation and homocysteine in ischemic stroke in the young age. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12‑2):25‑33. (In Russ.)
https://doi.org/10.17116/jnevro201711712225-33

Recommended articles:
Clinical and gene­tic asso­ciations in patients with non-cardioembolic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):12-19
Biomarkers of athe­rothrombotic and cardioembolic subtypes of acute ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):20-26
Clinical and tomo­graphic comparisons in patients with apha­sia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):27-33
Neuroimaging predictors of hemo­rrhagic transformation of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):34-38
Adva­nces in thro­mbectomy in the acute ischemic stroke. Russian Journal of Preventive Medi­cine. 2024;(10):137-143
Improving the effe­ctiveness of treatment of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):22-28
Myocardial infa­rction in young age. Russian Journal of Preventive Medi­cine. 2024;(11):77-84
The effe­ctiveness of drug therapy in the reha­bilitation of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):132-139
Anti-Inflammatory Effe­cts of Cold Atmo­spheric Plasma in the Mono­therapy of Mode­rate Acne. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):720-723
Oxidative stress and antioxidant protection in diso­rders of cere­bral circulation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):114-119

References:

  1. Dobrynina LA, Kalashnikova LA, Pavlova LN. Ischemic stroke in young age. Zh Nevrol Psikhiatr im. S.S. Korsakova. 2011;111(3):4-8. PMID: 21423109 (In Russ.)
  2. Palleiro O, López B. Etiologic subtypes of ischemic stroke in young adults aged 18 to 45 years: a study of a series of 93 patients. Rev Clin Esp. 2007;207(4):158-165. https://doi.org/10.1157/13101843
  3. Arnold M, Halpern M, Meier N, Fischer U, Haefeli T, Kappeler L, Brekenfeld C, Mattle HP, Nedeltchev K. Age-dependent differences in demographics, risk factors, co-morbidity, etiology, management, and clinical outcome of acute ischemic stroke. J Neurol. 2008;255(10):1503-1507. https://doi.org/10.1007/s00415-008-0949-9
  4. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M, Tatlisumak T. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke the Helsinki young stroke registry. Stroke. 2009;40(4):1195-1203. https://doi.org/10.1161/STROKEAHA.108.529883
  5. Howard G, Grau A. Advances in stroke. Population studies 2013. Stroke. 2014;45(2):368-370. https://doi.org/10.1161/STROKEAHA.113.004226
  6. Kalashnikova LA. Nevrologija antifosfolipidnogo sindroma. M.: Medicine; 2003. (In Russ.)
  7. Nasonov EL. Antifosfolipidnyj sindrom. M.: Litterra; 2004. (In Russ.)
  8. Nasonov EL, Martusevich NA. Antifosfolipidnyj sindrom: sovremennye predstavlenija. Lechebnoe delo: nauchno-prakticheskij terapevticheskij zhurnal. 2010;3(13):17-22. (In Russ.)
  9. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006;4:295-306. https://doi.org/10.1111/j.1538-7836.2006.01753.x
  10. Rahemtullah A, Van Cott EM. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med. 2007;131:890-901. https://doi.org/10.1043/1543-2165(2007)131[890:HTIIS]2.0
  11. Kay WP Ng, Loh PK, Sharma VK. Role of investigating thrombophilic disorders in young stroke. Stroke Res Treat. 2011:670138. https://doi.org/10.4061/2011/670138
  12. Kalaria C, Kittner S. The therapeutic value of laboratory testing for hypercoagulable states in secondary stroke prevention. Neuroi Clin. 2015;33(2):501-513. https://doi.org/10.1016/j.ncl.2015.01.003
  13. Pahus SH, Hansen AT, Hvas AM. Thrombophilia testing in young patients with ischemic stroke. Thromb Res. 2016;137:108-112. https://doi.org/10.1016/j.thromres.2015.11.006
  14. Martínez-Martínez M, Cazorla-García R, Rodríguez de Antonio LA, Martínez-Sánchez P, Fuentes B, Diez-Tejedor E. Hypercoagulability and ischemic stroke in young patients. Spanish Neurologia. 2010;25(6):343-348. https://doi.org/10.1016/s2173-5808(10)70065-1
  15. Kalashnikova LA, Dobrynina LA, Patrusheva NL, Kovalenko TF, Patrushev LI, Aleksandrova EN, Berkovskiĭ AL, Sergeeva EV, Nasonov EL. Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome. Ter Arkh. 2005;77(10):49-53. PMID: 16320685 (In Russ.)
  16. Dobrynina LA, Kalashnikova LA, Patrusheva NL, Kovalenko TF, Patrushev LI. Polymorphism of 5,10-methylenetetrahydropholate reductase, prothrombin, and coagulation factor V genes in young patients with ischemic stroke. Klin Med. 2012;90(3):37-40. PMID: 22690563 (In Russ.)
  17. Rasura M, Spalloni A, Ferrari M, De Castro S, Patella R, Di Lisi F, Beccia M. A case series of young stroke in Rome. Eur J Neurol. 2006;13(2):146-152. https://doi.org/10.1111/j.1468-1331.2006.01159.x
  18. Griffiths D, Sturm J. Epidemiology and etiology of young stroke. Stroke Res Treat. 2011; Article ID 209370. https://doi.org/10.4061/2011/209370
  19. Maksimova MYu. Malye glubinnye (lakunarnye) infarkty golovnogo mozga pri arterial’noj gipertonii i ateroskleroze [dissertation]. M. 2002. (In Russ.)
  20. Suslina ZA, Tanashjan MM, Ionova VG. Ishemicheskij insul’t, krov’, sosudistaja stenka, antitromboticheskaja terapija. M.: Medicinskaja kniga; 2005. (In Russ.)
  21. Vereshhagin NV, Suslina ZA, Piradov MA. Principy diagnostiki i lechenija bol’nyh s ostrymi ishemicheskimi narushenijami mozgovogo krovoobrashhenija. Nervnye bolezni. 2002;1:8-14. (In Russ.)
  22. Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 1997;17(11):3321-3325. https://doi.org/10.1161/01.atv.17.11.3321
  23. Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation. 2005;112:3080-3087. https://doi.org/10.1161/CIRCULATIONAHA.105.557132
  24. De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C. Von Willebrand factor: an emerging target in stroke therapy. Stroke. 2012;43(2):599-606. https://doi.org/10.1161/STROKEAHA.111.628867
  25. Wannamethee SG, Whincup PH, Lennon L, Rumley A, Lowe GD. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor and risk of incident stroke in older Men. Stroke. 2012;43(5):1206-1211. https://doi.org/10.1161/stroceana.111.636373
  26. Yang DT, Flanders MM, Kim H, Rodgers GM. Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events. Am J Clin Pathol. 2006;126:411-415. https://doi.org/10.1309/QC259F09UNMKVP0R
  27. Suri MFK, Yamagishi K, Aleksic N, Hannan PJ, Folsom AR. Novel hemostatic factor levels and risk of ischemic stroke: the atherosclerosis risk in communities (ARIC) study. Cerebrovasc Dis. 2010;29:497-502. https://doi.org/10.1159/000297966
  28. Dobrynina LA. Ishemicheskij insul’t v molodom vozraste: prichiny, klinika, diagnostika, prognoz vosstanovlenija dvigatel’nyh funkcij [dissertation]. M. 2013. (In Russ.)
  29. Kalashnikova LA, Dobrynina LA. Dissekcija arterij golovnogo mozga: ishemicheskij insul’t i drugie klinicheskie projavlenija. M.: Vako; 2013. (In Russ.)
  30. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013;36(1):1-5. https://doi.org/10.1159/000352050
  31. Oosting JD, Derksen RH, Blokzijl L, Sixma JJ, de Groot PG. Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity — studies in a thrombosis model. Thromb Haemost. 1992;68:278-284. PMID: 1440492.
  32. Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest. 1995;96:2211-2219. https://doi.org/10.1172/JCI118276
  33. Hoppensteadt DA, Fabbrini N, Bick RL, Messmore HL, Adiguzel C, Fareed J. Laboratory evaluation of the antiphospholipid syndrome. Hematol Oncol Clin North. 2008;22:19-32. https://doi.org/10.1016/j.hoc.2007.10.009
  34. Reininger AJ. Function of von Willebrand factor in haemostasis and thrombosis. Haemophilia. 2008;14(5):11-26. https://doi.org/10.1111/j.1365-2516.2008.01848.x
  35. Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 2003;34:632-636. https://doi.org/10.1161/01.STR.0000060203.58958.35
  36. Vandresse JH, de Saint Hubert E, Evrard P. Homocystinuria and carotid arteriography. Neuroradiology. 1978;17:57-58. https://doi.org/10.1007/bf00345271
  37. Wicherink-Bol HF, Boers GH, Drayer JI, Rosenbusch G. Angiographic findings in homocystinuria. Cardiovasc Intervent Radiol. 1983;6:125-128. https://doi.org/10.1007/bf02552761
  38. Barkagan ZS, Momot AP. Diagnostika i kontroliruemaja terapija narushenij gemostaza. M.: N’judiamed; 2001. (In Russ.)
  39. Rodrigues CEM, Carvalho JF, Shoenfeld Y. Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest. 2010;40(4):350-359. https://doi.org/10.1111/j.1365-2362.2010.02263.x

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.